Sterling Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.99K	Sell	413 -305	-42%	-$3.54K	﹤0.01%	2649
2025 Q4	$6.9K	Sell	718 -142	-17%	-$1.36K	﹤0.01%	2774
2025 Q3	$8.08K	Buy	860 +563	+190%	+$5.38K	﹤0.01%	2605
2025 Q2	$3.14K	Buy	297 +113	+61%	+$1.43K	﹤0.01%	2761
2025 Q1	$2.77K	Sell	184 -181	-50%	-$3.01K	﹤0.01%	2454
2024 Q4	$6.01K	Buy	365 +324	+790%	+$6.39K	﹤0.01%	2376
2024 Q3	$1.01K	Buy	+41	New	+$1.06K	﹤0.01%	2523
2015 Q1	–	Sell	-44,916	Closed	-$1.83M	–	870
2014 Q4	$1.83M	Sell	44,916 -316	-0.7%	-$12.4K	0.02%	430
2014 Q3	$1.66M	Buy	45,232 +1,037	+2%	+$44.8K	0.02%	444
2014 Q2	$2.05M	Buy	44,195 +1,063	+2%	+$47.3K	0.02%	341
2014 Q1	$1.77M	Buy	43,132 +31,362	+266%	+$1.17M	0.02%	368
2013 Q4	$449K	Buy	11,770 +933	+9%	+$28.8K	﹤0.01%	621
2013 Q3	$259K	Buy	+10,837	New	+$243K	﹤0.01%	605